by Dolly the Sheep | Sep 15, 2025 | Cancer, Immunology, Organoids, Stem Cell, Tissue Engineering
Why Animal-Based ECMs Have No Place in the Future of 3D Cell Models In 2025, the FDA and NIH initiated a major push to phase out animal testing, promoting New Approach Methodologies (NAMs) like organoids and AI models. However, a significant contradiction undermines...
by Dolly the Sheep | Sep 9, 2025 | Cancer, CGT Research, Disease Modelling, Drug Discovery, Immunology, Neurology, Tissue Engineering, Virology
Introducing primary cells by abm Primary cells are directly isolated from living tissues and retain many of the physiological characteristics of their tissue of origin. Unlike immortalized or transformed cell lines, primary cells offer more biologically relevant...
by Dolly the Sheep | Sep 9, 2025 | Drug Discovery, Virology
POSTER FROM GENETEX Download poster: MpoxVirus (MPXV) Monkeypox (Mpox) virus (MPXV) is the causative agent of the zoonotic disease known as Mpox, which infects both humans and animals. First detected in monkeys in 1959, the first human case was diagnosed 12 years...
by Dolly the Sheep | Sep 9, 2025 | Drug Discovery, Neurology, Stem Cell
New product: Recombinant human IL-34 PLUS™ protein (Qk091) from Qkine Interleukin-34 (IL-34) is a cytokine involved in regulating the differentiation, survival, and activation of monocytes, macrophages, and osteoclasts. IL-34 plays a key role for the development and...
by Dolly the Sheep | Sep 9, 2025 | Cancer, Disease Modelling, Drug Discovery, Immunology, in vivo Studies
IN VIVO ANTIBODIES FROM BIO X CELL Recombinant PD-1: Consistent performance from pilot studies through translational research PD-1 (CD279) is a central immune checkpoint receptor that downregulates T cell activity to maintain tolerance and prevent autoimmunity. By...
